🇺🇸 FDA

Intelligence · Patent portfolio

Essential Pharma Patents

Full USPTO pharma patent portfolio for Essential Pharma — grant dates, expiration, and drug cross-links.

Patents
95
Expiring ≤24m
2

Quick answer

Essential Pharma has 95 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 2

  1. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12350258

    Compositions and methods for treatment of skin-related diseases and promoting dermatological health

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12343381

    Dosage regimen for pegylated interferon

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12343348

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12178823

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12109216

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12005081

    Chimeric receptors and methods of use thereof

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11884656

    Pyrrole derivatives as PLK1 inhibitors

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11826429

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11786536

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11786524

    Pharmaceutical compounds

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11690933

    Absorbent aliphatic polyurethane foam product

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11559567

    Dosage regimen for pegylated interferon

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11445997

    Ultrasound imaging of biomarker sensitive hydrogels

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11446332

    Combinatorial cancer immunotherapy

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11419898

    Combinatorial cancer immunotherapy

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11285163

    Ophthalmic solution

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11273191

    Administering compositions for improved immune system functioning

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11208405

    Pyrrole derivatives as PLK1 inhibitors

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11045478

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10993967

    Combinatorial cancer immunotherapy

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10973817

    Pharmaceutical compounds

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10874676

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10869846

    N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10730882

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10722581

    Phonophoretic cannabidiol composition and transdermal delivery system

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10702590

    Compositions and methods for treating thyroid disease

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10632198

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10555997

    Antigens and vaccines directed against human enteroviruses

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10548964

    Antigens and vaccines directed against human enteroviruses

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10517869

    Topical brimonidine tartrate ophthalmic solution

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10463674

    Process for manufacturing sterile ophthalmic pharmaceutical suspensions

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10456408

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10398776

    Phonophoretic cannabidiol composition and transdermal delivery system

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10369182

    Compositions and methods for treating insomnia and other sleep related disorders

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10344033

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10154681

    Goitrogen-free beverage, methods of use and method of formulating the same

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10144726

    Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10105289

    Biomimetic mineral based endodontic cement composition and uses thereof

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10098379

    Device and method for simulating chemosensation of smoking

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10085998

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10058557

    Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9987350

    Antigens and vaccines directed against human enteroviruses

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9820991

    Pharmaceutical composition comprising brinzolamide

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9801813

    Preservative-free ophthalmic pharmaceutical formulation

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9782416

    Pharmaceutical formulations of potassium ATP channel openers and uses thereof

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9765043

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9757209

    Compositions and methods for dental applications involving zinc-oxide cements

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Essential Pharma have?

95 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Essential Pharma patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.